In contrast, KLF6 was able to transactivate multiple genes that negatively regulated the NF-κB pathway, thereby decreasing the nuclear localization of NF-κB and downregulating the expression of its target genes in glioblastoma [29]. The gene discussed is NFKB1; the disease is glioblastoma.